Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.
about
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsPharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy AdultsIsavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of 14 C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers.
P2860
Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@en
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@nl
type
label
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@en
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@nl
prefLabel
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@en
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic Interaction Be ...... ir 100 mg in Healthy Subjects.
@en
P2093
Amit Desai
Christopher Lademacher
Donna Kowalski
Laura Kovanda
Robert Townsend
Shahzad Akhtar
Takao Yamazaki
P2860
P304
P356
10.1002/CPDD.282
P577
2016-06-08T00:00:00Z